Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting with NLK.
Smads are important intracellular effectors in signaling pathways of the transforming growth factor-beta (TGF-beta). Receptor-activated Smads combine with a common Smad4 to translocate into the nucleus where they cooperate with other transcription factors to activate or repress transcription. SMAD4 is an important tumor suppressor gene. Smad4 has been shown to be constitutively phosphorylated, but the kinase that performs this phosphorylation is unknown. In this study, Smad4 was identified to interact with Nemo-like kinase (NLK) by a yeast two-hybrid system, and this interaction was confirmed in vitro and in vivo. Furthermore, the linker sequence of Smad4 is sufficient for this specific interaction. NLK is a conserved Ser/Thr kinase. Using in vitro kinase assays, we identified that threonine 9 (Thr9) and Serine 138 (Ser138) within the N-terminal Mad homology1 (MH1) domain of Smad4 could be phosphorylated by NLK. Our research suggests that NLK may play a novel role in the regulatory of Smad4 through phosphorylation.
Shi
Yan
Y
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Rd, 200433, Shanghai, People's Republic of China.
Ye
Kan
K
Wu
Huiling
H
Sun
Yixing
Y
Shi
Huili
H
Huo
Keke
K
D001665:Binding Sites; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D010766:Phosphorylation; D011485:Protein Binding; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D012694:Serine / Q000378:metabolism; D051901:Smad4 Protein / Q000378:metabolism*; D013912:Threonine / Q000378:metabolism; D020798:Two-Hybrid System Techniques
D047908:Intracellular Signaling Peptides and Proteins; D051901:Smad4 Protein; D013912:Threonine; D012694:Serine; C470551:NLK protein, human; D017346:Protein Serine-Threonine Kinases
Nature. 1997 Jul 3;388(6637):87-93
9214508
J Biol Chem. 2006 Jul 28;281(30):20749-20760
16714285
Curr Opin Cell Biol. 1996 Apr;8(2):205-15
8791420
Chin Med J (Engl). 2002 Mar;115(3):446-50
11940386
Mol Cell Biol. 2003 Jan;23(1):131-9
12482967
J Biol Chem. 2001 Aug 3;276(31):29531-7
11371552
Genes Dev. 2004 Apr 1;18(7):816-29
15082531
Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):5-13
10708948
J Biol Chem. 2005 Jun 10;280(23):22115-23
15817471
J Biol Chem. 2003 Jul 25;278(30):27853-63
12740389
Am J Physiol Cell Physiol. 2003 Oct;285(4):C823-30
12801888
Development. 2007 Jun;134(11):2061-71
17507407
J Biol Chem. 2003 Aug 15;278(33):31043-8
12813045
Trends Genet. 2000 Jul;16(7):279-83
10858654
J Cell Sci. 2001 Dec;114(Pt 24):4359-69
11792802
Mol Cell Biol. 2003 Feb;23(4):1379-89
12556497
EMBO J. 1998 Feb 16;17(4):996-1005
9463378
Mol Biol Cell. 2005 Oct;16(10):4705-13
16055500
EMBO J. 1997 Sep 1;16(17):5353-62
9311995